Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5151
CALL
Commault Systems
CVLT
$5.47B
| $61K | ﹤0.01% |
1,000
+700
| +233% | +$41.8K |
|
|
5152
PUT
Commault Systems
CVLT
$5.47B
| $61K | ﹤0.01% |
+1,000
| New | +$59.7K |
|
5153
PUT
Hormel Foods
HRL
$13.9B
| $61K | ﹤0.01% |
1,900
-100
| -5% | -$3.27K |
|
5154
CALL
JetBlue
JBLU
$2.42B
| $61K | ﹤0.01% |
3,300
-88,100
| -96% | -$1.85M |
|
5155
Mercury Systems
MRCY
$6.77B
| $61K | ﹤0.01% |
1,187
-4,516
| -79% | -$208K |
|
5156
Northern Oil and Gas
NOG
$2.22B
| $61K | ﹤0.01% |
6,780
+1,903
| +39% | +$19.4K |
|
5157
CALL
Wabtec
WAB
$50.5B
| $61K | ﹤0.01% |
800
-600
| -43% | -$46.2K |
|
5158
ProShares UltraShort Yen
YCS
$29.4M
| $61K | ﹤0.01% |
3,284
-3,804
| -54% | -$68.6K |
|
|
RP
5159
DELISTED
RealPage, Inc.
RP
| $61K | ﹤0.01% |
1,539
-1,777
| -54% | -$70.8K |
|
|
CASC
5160
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $61K | ﹤0.01% |
15,000
+14,969
| +48,287% | +$57.3K |
|
|
GTT
5161
DELISTED
GTT Communications, Inc.
GTT
| $61K | ﹤0.01% |
1,934
-2,745
| -59% | -$83.9K |
|
|
STMP
5162
CALL
DELISTED
Stamps.com, Inc.
STMP
| $61K | ﹤0.01% |
300
-900
| -75% | -$165K |
|
5163
Hudbay
HBM
$11B
| $60K | ﹤0.01% |
7,977
+7,577
| +1,894% | +$57K |
|
5164
Hamilton Lane
HLNE
$5.61B
| $60K | ﹤0.01% |
2,228
-784
| -26% | -$18K |
|
5165
iShares US Regional Banks ETF
IAT
$689M
| $60K | ﹤0.01% |
1,272
+900
| +242% | +$40.7K |
|
5166
IDT Corp
IDT
$1.67B
| $60K | ﹤0.01% |
4,951
-3,350
| -40% | -$41.3K |
|
5167
PUT
Ingredion
INGR
$6.6B
| $60K | ﹤0.01% |
500
-300
| -38% | -$36.6K |
|
5168
CALL
Pitney Bowes
PBI
$2.52B
| $60K | ﹤0.01% |
4,300
-16,700
| -80% | -$229K |
|
5169
Perdoceo Education
PRDO
$2.06B
| $60K | ﹤0.01% |
5,851
-60,366
| -91% | -$559K |
|
5170
SEACOR Marine Holdings
SMHI
$257M
| $60K | ﹤0.01% |
3,833
-30,361
| -89% | -$442K |
|
5171
SouthState Bank Corp
SSB
$10.6B
| $60K | ﹤0.01% |
670
-645
| -49% | -$53.9K |
|
5172
TriCo Bancshares
TCBK
$1.87B
| $60K | ﹤0.01% |
1,484
+867
| +141% | +$31.3K |
|
5173
ProShares UltraShort Russell2000
TWM
$41.2M
| $60K | ﹤0.01% |
+161
| New | +$67.4K |
|
|
LGF.B
5174
PUT
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $60K | ﹤0.01% |
1,900
| – | – |
|
|
EGRX
5175
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $60K | ﹤0.01% |
1,007
-28,462
| -97% | -$1.72M |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.